News Category
Viromed Medical AG signs distribution agreements for its cold plasma device ViroCAP® in six new markets, expecting at least 3,000 additional device sa...
Quantum BioPharma announced FDA approval of its IND application for Lucid-MS, a first-in-class neuroprotective candidate for multiple sclerosis, allow...
PX1 Research introduces US-manufactured sublingual peptide strips, including Retatrutide, offering a needle-free alternative for academic research wit...
PX1 Research's expansion of cGMP quality control and HPLC purity verification to all its US-manufactured research peptides provides academic and resea...
NanoViricides has received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a mor...
New research from the University of Virginia suggests focused ultrasound may make brain tumor treatments more effective and less harmful, potentially ...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth and metastasis in TNBC models, supporting ...
Park-Ohio's second quarter results indicate a turning point as higher-margin businesses improve, leading to raised guidance and a potential portfolio ...
ICON Smile Studios' new flagship campuses in Virginia Beach and Norfolk mark a significant expansion in integrated specialty dental care, continuing a...
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz, a veteran with 30 years of experience, to oversee supply ...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a potential neuroprotective therapy for mult...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, led by TONMYA sales, marking a significant commercial milestone and providing cash run...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by strong sales of its fibromyalgia drug TONMYA, marking a significant c...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, fueled by TONMYA sales, while the company progresses its clinical pipeline, signaling ...
Voyageur's Mueller iodine extraction process achieves high purity and recovery in lab tests, advancing its plan for a domestic iodine supply and field...
OffScript introduces FOCUS+FLOW and CALM+COLLECTED, sublingual nootropic mints with fully disclosed dosing and third-party testing, reflecting a shift...
A new narrative review in the World Journal of Pediatric Surgery provides a comprehensive, risk-based framework for diagnosing and treating neuroblast...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through key clinical, regulatory, and commercial stages, positionin...
Quantum BioPharma is advancing a two-pronged approach to neurological health, focusing on its MS therapy Lucid-MS and alcohol metabolism supplement un...
Quantum BioPharma is progressing its two-pronged approach to neurological health, advancing its MS therapy Lucid-MS and its alcohol metabolism supplem...
VERAXA Biotech's next-generation antibody platforms, including ADCs and T-cell engagers, position it to attract significant pharma investment and part...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the importance of proper food preparation and the need for...
Veetee USA appoints Kevin Stitt to spearhead retail expansion at Walmart and Publix, leveraging domestic manufacturing and a unique steam-cooking proc...
Lantern Pharma's upcoming Q2 2026 webcast will detail financial results and progress on its AI-driven oncology platforms, underscoring the company's s...
Earth Science Tech's fiscal Q1 2027 results show a 57% net income increase, signaling robust financial health and strategic progress in its healthcare...
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor...
VERAXA Biotech has advanced its VXA-222 bispecific ADC program beyond discovery and expanded its patent portfolio, strengthening its position in next-...
American Fusion Inc. has filed six additional U.S. patent applications, bringing its total to 82, and is progressing toward OTCQB listing and next-pha...
Nano-X Imaging's $8 million registered direct offering with a long-term institutional investor provides capital to advance its preventive healthcare i...
A new liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatment...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, supporting the scheduled Q4 20...
Innovative Designs, Inc. announces its best quarter ever with near 40% revenue growth and ongoing expansion, signaling strong market adoption of its I...
The July Wellness Index Report highlights a shift in longevity from external interventions to working with the body's own hormones, cells, and microbi...
The July Wellness Index Report reveals a trend in longevity medicine toward enhancing the body's natural processes, with implications for hormone heal...
Regentis Biomaterials' GelrinC, a cell-free hydrogel implant for knee cartilage repair, gains European approval for a next-generation manufacturing pr...
Purple Exhibits announces Joey Bartman's expanded oversight for all KBIS 2027 projects, ensuring specialized expertise and quality control for exhibit...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to advance its lead candidate ONC010, potentially imp...
Earth Science Tech's strategic focus on proprietary technology and vertical integration positions it to capitalize on the growing telehealth and pepti...
Episode 812 of DH Unplugged dissects a turbulent week where Big Tech earnings caused massive swings, Korea's KOSPI crashed, and SpaceX faced a post-IP...
Researchers at Nagoya University discovered that the immune protein C3, when produced within tumors, can boost the effectiveness of immunotherapy, off...
American Fusion's presentation of its Texatron Fusion Engine and GEM Unification Theory at the APS DPF 2026 Meeting underscores the company's active r...
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with implication...
Tonix Pharmaceuticals announced its participation in two upcoming investor conferences, highlighting its commitment to engaging with the investment co...
VERAXA Biotech announced the advancement of its VXA-222 bispecific antibody-drug conjugate program beyond the discovery phase, leveraging OmniAb's ant...
LataMed AI will discuss AI's role in healthcare and systems engineering at a Venezuelan university conference, highlighting its commitment to responsi...
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a novel cannabinoid-based treatment for Tourette Synd...
Medios AG hires veteran capital markets expert Katrin Neuffer to lead investor relations and communications, aiming to strengthen its market positioni...
SRX Global's investment in Vistagen Therapeutics highlights a strategic move to capitalize on undervalued neuroscience assets and potentially drive sh...
